News & Analysis as of

Weight-Loss Products Telemedicine

Stevens & Lee

GLP-1 Weight Loss Drug Enforcement in 2025: State Attorneys General Step into a Growing Regulatory Gap

Stevens & Lee on

The rapid rise of GLP-1 weight loss drugs such as semaglutide and tirzepatide has created two parallel markets. One market consists of FDA-approved products used under typical prescribing conditions. The other is a patchwork...more

Ankura

Beyond the Prescription: Ozempic's Influence on Health, Retail, and Consumer Behavior

Ankura on

Ozempic's meteoric rise has reshaped the landscape of healthcare, retail, and consumer behavior. Its initial popularity as a weight loss medication has sparked a broader conversation around health, wellness, and body image....more

Foley & Lardner LLP

Florida Board of Medicine to Reconsider Telemedicine Weight Loss Rule

Foley & Lardner LLP on

The Florida Board of Medicine will hold a rule development workshop to discuss updating the provisions of its rule for prescribing obesity drugs. Under the current rule (Florida Administrative Code 64B8-9.012), a physician...more

3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide